Effect of Rasagiline in Patients With Parkinson's Disease

- Parkinson's Disease
- Completed

Study Title: ParFemale, Maleel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

Teva Identifier: TVP-1012/PM106

ClinicalTrials.gov Identifier: NCT01723228

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: Rasagiline | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 45 Years to 80 Years

Trial Duration: 11/01/2012 - 01/01/2015

Phase: Phase 4

Study Type

Interventional